A similar pattern was observed for ER+/HER2− tumours and with triple-negative tumours under around 100 mm3; however, for HER2+ tumours the prevalence of lymph node metastases began to increase around 14.1 mm3 (3 mm diameter) (Supplementary Fig. 4). This evidence concerns the gene ERBB2 and neoplasm.